These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8382801)

  • 1. Characterization of an altered DNA catalysis of a camptothecin-resistant eukaryotic topoisomerase I.
    Gromova II; Kjeldsen E; Svejstrup JQ; Alsner J; Christiansen K; Westergaard O
    Nucleic Acids Res; 1993 Feb; 21(3):593-600. PubMed ID: 8382801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Camptothecin inhibits both the cleavage and religation reactions of eukaryotic DNA topoisomerase I.
    Kjeldsen E; Svejstrup JQ; Gromova II; Alsner J; Westergaard O
    J Mol Biol; 1992 Dec; 228(4):1025-30. PubMed ID: 1335513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site.
    Svejstrup JQ; Christiansen K; Gromova II; Andersen AH; Westergaard O
    J Mol Biol; 1991 Dec; 222(3):669-78. PubMed ID: 1660929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single mutation in the linker domain confers protein flexibility and camptothecin resistance to human topoisomerase I.
    Fiorani P; Bruselles A; Falconi M; Chillemi G; Desideri A; Benedetti P
    J Biol Chem; 2003 Oct; 278(44):43268-75. PubMed ID: 12904303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The different cleavage DNA sequence specificity explains the camptothecin resistance of the human topoisomerase I Glu418Lys mutant.
    Fiorani P; Chillemi G; Losasso C; Castelli S; Desideri A
    Nucleic Acids Res; 2006; 34(18):5093-100. PubMed ID: 16990249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Camptothecins inhibit the utilization of hydrogen peroxide in the ligation step of topoisomerase I catalysis.
    Lisby M; Krogh BO; Boege F; Westergaard O; Knudsen BR
    Biochemistry; 1998 Jul; 37(30):10815-27. PubMed ID: 9692972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A camptothecin-resistant DNA topoisomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons.
    Knab AM; Fertala J; Bjornsti MA
    J Biol Chem; 1995 Mar; 270(11):6141-8. PubMed ID: 7890748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An engineered mutant of vaccinia virus DNA topoisomerase I is sensitive to the anti-cancer drug camptothecin.
    Gupta M; Zhu CX; Tse-Dinh YC
    J Biol Chem; 1992 Dec; 267(34):24177-80. PubMed ID: 1332948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a camptothecin-resistant human DNA topoisomerase I.
    Kjeldsen E; Bonven BJ; Andoh T; Ishii K; Okada K; Bolund L; Westergaard O
    J Biol Chem; 1988 Mar; 263(8):3912-6. PubMed ID: 2831213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I.
    Das BB; Sen N; Roy A; Dasgupta SB; Ganguly A; Mohanta BC; Dinda B; Majumder HK
    Nucleic Acids Res; 2006; 34(4):1121-32. PubMed ID: 16488884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CPT on the DNA cleavage/religation reaction mediated by calf thymus Topoisomerase I: evidence of an inhibition of DNA religation. Inhibition of Topoisomerase I-mediated DNA religation by CPT.
    Carboni MC; Coderoni S
    Mol Biol Rep; 1994-1995; 20(3):129-33. PubMed ID: 7565652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mutations in the F361 to R364 region of topoisomerase I (Topo I), in the presence and absence of 9-aminocamptothecin, on the Topo I-DNA interaction.
    Pond CD; Li XG; Rubin EH; Barrows LR
    Anticancer Drugs; 1999 Aug; 10(7):647-53. PubMed ID: 10507314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
    Jaxel C; Kohn KW; Pommier Y
    Nucleic Acids Res; 1988 Dec; 16(23):11157-70. PubMed ID: 2849758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of amino acids 361 to 364 of human topoisomerase I in camptothecin resistance and enzyme catalysis.
    Li XG; Haluska P; Hsiang YH; Bharti AK; Kufe DW; Liu LF; Rubin EH
    Biochem Pharmacol; 1997 Apr; 53(7):1019-27. PubMed ID: 9174116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecin.
    Kapoor R; Slade DL; Fujimori A; Pommier Y; Harker WG
    Oncol Res; 1995; 7(2):83-95. PubMed ID: 7579731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting topoisomerase I cleavage to specific sequences of DNA by triple helix-forming oligonucleotide conjugates. A comparison between a rebeccamycin derivative and camptothecin.
    Arimondo PB; Bailly C; Boutorine A; Sun JS; Garestier T; Hélène C
    C R Acad Sci III; 1999 Sep; 322(9):785-90. PubMed ID: 10547719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of topoisomerase I gene point mutation in CPT-11 resistant lung cancer cell line.
    Kubota N; Kanzawa F; Nishio K; Takeda Y; Ohmori T; Fujiwara Y; Terashima Y; Saijo N
    Biochem Biophys Res Commun; 1992 Oct; 188(2):571-7. PubMed ID: 1332703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning of a cDNA of a camptothecin-resistant human DNA topoisomerase I and identification of mutation sites.
    Tamura H; Kohchi C; Yamada R; Ikeda T; Koiwai O; Patterson E; Keene JD; Okada K; Kjeldsen E; Nishikawa K
    Nucleic Acids Res; 1991 Jan; 19(1):69-75. PubMed ID: 1849260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavage.
    Kjeldsen E; Mollerup S; Thomsen B; Bonven BJ; Bolund L; Westergaard O
    J Mol Biol; 1988 Jul; 202(2):333-42. PubMed ID: 2845097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human DNA topoisomerase I mutant Gly717Asp: Higher religation rate is not always associated with camptothecin resistance.
    Wang Z; D'Annessa I; Tesauro C; Ottaviani A; Soren BC; Dasari JB; Messina B; Thareparambil A; Fiorani P
    Arch Biochem Biophys; 2019 Mar; 663():165-172. PubMed ID: 30653963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.